top of page

Interested in collaborating with BBT?

Beyond Barriers Therapeutics is actively seeking partners in science, medicine, and investments as we revolutionize the way concussions are treated.

Scientist preparing intranasal brain injury treatment in laboratory
Beyond Barriers Therapeutics brand logo for brain injury treatment

Beyond Barriers Therapeutics’ revolutionary therapy, BBT-101, is the first-of-its-kind, intranasal treatment for concussions.

  © 2025 by Beyond Barriers Therapeutics, Inc.

info@beyondbarrierstherapeutics.com

DISCLAIMER: This website contains information about a drug that has not been approved by the FDA for the specific use or uses suggested. Use of NAC to treat CNS disorders is an unapproved use and the safety and effectiveness of NAC in the treatment of CNS disorders has not been established. Beyond Barriers Therapeutics does not recommend, endorse, or suggest using NAC for any unapproved use, including intranasal administration of NAC for the treatment of concussion or TBI.  This website is not intended to provide medical advice, diagnoses, or treatment recommendations.  Instead, this website provides useful scientific information on a promising new therapy that is currently under active clinical development.  Patients and healthcare professionals should not rely on the information presented in this website to make any healthcare decisions, including, but not limited to, prescribing or using NAC for any off-label or unapproved use.

*Source: Abbott Labs

Site by Duet Creative

bottom of page